| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 860 | $52.70 | $45,325.44 | -0.6% | -25.7% | -38.7% | |
| Dec 6, 2024 | NOTV Inotiv, Inc. | Harrington Michael J | Director | Buy | 10,000 | $3.98 | $39,822.00 | +36.4% | -30.0% | -78.7% | |
| Dec 6, 2024 | NOTV Inotiv, Inc. | Landman David | Director | Buy | 100,000 | $4.14 | $414,000.00 | +187.5% | -30.0% | -78.7% | |
| Dec 6, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 2,216 | $52.70 | $116,792.06 | -0.3% | -25.7% | -38.7% | |
| Dec 5, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 5,127 | $31.35 | $160,741.70 | -2.0% | -33.7% | +20.1% | |
| Dec 5, 2024 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 3,504 | $51.85 | $181,696.32 | -7.4% | -17.1% | -36.3% | |
| Dec 5, 2024 | IMDX Insight Molecular Diagnostics Inc. | James Andrea S.68 | Chief Financial Officer | Buy | 20,000 | $2.29 | $45,800.00 | +59.4% | +57.4% | +127.8% | |
| Dec 4, 2024 | CDNA Caredx, Inc. | Novack Jeffrey Adam68 | Secretary And General Counsel | Sell | 1,917 | $26.00 | $49,842.00 | -1.7% | -21.7% | -25.1% | |
| Dec 4, 2024 | VCYT Veracyte, Inc. | McGuire Annie46 | SVP, General Counsel | Sell | 18,699 | $44.02 | $823,178.60 | -20.4% | -22.6% | +7.5% | |
| Dec 4, 2024 | VCYT Veracyte, Inc. | Febbo Phillip G.63 | Chief Scientific &Med Officer | Sell | 3,934 | $44.09 | $173,447.31 | -4.6% | -22.6% | +7.5% | |
| Dec 3, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,867 | $30.98 | $243,692.99 | -19.7% | -30.9% | +28.0% | |
| Dec 3, 2024 | IQV Iqvia Holdings Inc. | Danhakl John G60 | Director | Buy | 1,275 | $200.58 | $255,739.50 | New | -7.8% | +13.3% | |
| Dec 3, 2024 | MTD Mettler Toledo International Inc/ | Keller Gerry64 | Head Of Process Analytics | Sell | 140 | $1,254.09 | $175,572.60 | -95.9% | +0.9% | +14.1% | |
| Dec 3, 2024 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 1,373 | $19.50 | $26,773.36 | -0.1% | -21.8% | +45.7% | |
| Dec 3, 2024 | PMDI Psychemedics Corp | Kamin Peter | - | Buy | 1,409,712 | $2.35 | $3,312,823.20 | +343.2% | - | - | |
| Dec 3, 2024 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,455 | $19.50 | $28,372.35 | -0.4% | -21.8% | +45.7% | |
| Dec 3, 2024 | VCYT Veracyte, Inc. | Leite John49 | Chief Commercial Officer-clia | Sell | 1,050 | $43.25 | $45,407.88 | -1.4% | -23.1% | +9.4% | |
| Dec 3, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $531.23 | $10,624,558.87 | -1.3% | -2.0% | +8.6% | |
| Dec 3, 2024 | VCYT Veracyte, Inc. | Wygant Jonathan | VP, Chief Accounting Officer | Sell | 956 | $43.36 | $41,452.45 | -2.3% | -23.1% | +9.4% | |
| Dec 3, 2024 | VCYT Veracyte, Inc. | Chambers Rebecca73 | Chief Financial Officer | Sell | 7,000 | $43.23 | $302,621.90 | -5.8% | -23.1% | +9.4% | |
| Dec 2, 2024 | RVTY Revvity, Inc. | Singh Prahlad R.53 | Please See Remarks | Sell | 18,365 | $116.22 | $2,134,365.95 | -9.1% | -5.4% | -12.0% | |
| Dec 2, 2024 | GH Guardant Health, Inc. | Joyce Meghan V.56 | Director | Sell | 100 | $35.90 | $3,590.00 | -1.3% | +14.7% | +192.4% | |
| Dec 2, 2024 | NTRA Natera, Inc. | Botha Roelof81 | Director | Sell | 87,473 | $169.12 | $14,793,563.23 | -1.4% | -15.7% | +39.3% | |
| Dec 2, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 263 | $78.39 | $20,616.89 | -1.1% | +22.2% | +107.9% | |
| Nov 29, 2024 | OPK Opko Health, Inc. | Frost Phillip Md Et Al48 | CEO &Chairman | Buy | 199,072 | $1.53 | $305,376.45 | - | +5.8% | -11.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.